Report cover image

United States Anesthesia Drugs Market, Size, Forecast 2022-2027, Industry Trends, Share, Growth, Impact of COVID-19, Opportunity Company Analysis

Publisher Renub Research
Published Jan 01, 2022
Length 155 Pages
SKU # RNBR16906316

Description

United States Anesthesia Drugs Market, Size, Forecast 2022-2027, Industry Trends, Share, Growth, Impact of COVID-19, Opportunity Company Analysis

The United States is a prominent regional market for the anesthesia drugs industry. The region is home to heavyweights in the pharmaceutical sector looking to increase their stakes in the United States market. Anesthesia is a drug-induced, reversible condition that includes specific behavioral and physiological traits amnesia, unconsciousness, analgesia, and akinesia with concomitant stability of the cardiovascular, autonomic, respiratory, and thermoregulatory systems. Anesthesia drugs are one of the primary elements of any surgical procedure. It causes temporary unconsciousness and loss of protective reflexes. According to Renub Research report, United States Anesthesia Drugs Market will reach US$ 6.2 Billion by 2027.

Besides, United States anesthesia drugs market is driven by factors, such as the growing geratic population, increasing incidence of cardiovascular cases, and rising number of urgent surgeries in the United States. Private and public health insurers like Aetna International, Anthem Blue Cross and Blue Shield, Medicare etc. are helping to boost this market by considering anesthetic drug in their reimbursement policy. As per our Research findings, United States Anesthesia Drugs Market will grow with a CAGR of 4% from 2021-2027.

Covid-19 Impact on the United States Anesthesia Drugs Industry:

The COVID-19 pandemic has significantly affected the United States anesthesia drugs market. The anesthesia drugs sector is seeing difficulties in the supply chain and manufacturing, such as attending to an uneven demand for products and delivering products to end-users on time. It can be attributed to the deterioration in the product demand from major end-users, inadequate surgeries in most hospitals, and interrupted supply chain and challenges in providing essential services due to lockdowns.

General Inhalation Anesthesia Drugs Market holds the Largest Market Share

On the basis of type, United States anesthesia drugs market includes General Inhalation Anesthesia Drugs market, General Intravenous Anesthesia Drugs Market and Local Anesthesia Drugs Market. General Inhalation Anesthesia Drugs Market holds the largest market share, the inhaled anesthetics include sevoflurane, desflurane, isoflurane, and other are thought to enhance inhibitory postsynaptic channel activity and inhibit excitatory synaptic activity.

Further, general intravenous anesthesia is the leading segments in the United States anesthesia drug market. Benzodiazepines Class, Propofol, Ketamine, Methohexital Sodium, Fospropofol Disodium, Pentobarbital, Etomidate and Fentanyl are commonly used general intravenous anesthesia in the United States. Benzodiazepines and Propofol and Class are the leading anesthesia drugs among this anaesthesia.

United States Anesthesia Drugs Market Size was US$ 4.9 Billion in 2021

In the United States local anesthesia drugs market, bupivacaine is a prescription medicine utilized as a local anesthetic that prevents the nerve impulses that send pain signals to the brain. This medicine is a very useful anesthetic for regional and local anesthesia for several procedures, such as therapeutic, surgery and diagnostic and obstetrical procedures. It is used in various surgical procedures in the United States.

Major Players:

In the United States anesthesia drugs industry several players are selling their products. Most of the anesthesia drugs trade is generic, available at a low cost. The major drug companies working in this field are Baxter International Inc., Abbvie, Endo International plc, Draegerwerk AG, and Koninklijke Philips NV.

Renub Research latest Report ""United States Anesthesia Drugs Market by Type (General Inhalation Anesthesia Drugs market, General Intravenous Anesthesia Drugs Market and Local Anesthesia Drugs Market) by General Inhalation Anesthesia Drugs market (Benzodiazepines Class, Propofol, Ketamine, Methohexital Sodium, Fospropofol Disodium, Pentobarbital, Etomidate and Fentanyl) by General Intravenous Anesthesia Drugs Market (sevoflurane, desflurane, isoflurane, and other) by Local Anesthesia Drugs Market (Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Prilocaine, Benzocaine, Other local anesthetics) by Company Analysis (Baxter International Inc., Abbvie, Endo International plc, Draegerwerk AG, and Koninklijke Philips NV)"" provides complete details on United States Anesthesia Drugs Market

Types – United States Anesthesia Drugs Market breakup by 3 viewpoints

1. General Intravenous Anesthesia Drugs Market
2. General Inhalation Anesthesia Drugs Market
3. Local Anesthesia Drugs Market

General Intravenous Anesthesia Drugs Market breakup by 8 viewpoints

1. Propofol
2. Benzodiazepines Class (Diazepam and Midazolam)
3. Fospropofol Disodium
4. Ketamine
5. Methohexital Sodium
6. Pentobarbital
7. Etomidate
8. Fentanyl

General Inhalation Anesthesia Drugs Market breakup by 4 viewpoints

1. Sevoflurane
2. Desflurane
3. Isoflurane
4. Others

Local Anesthesia Drugs Market breakup by 7 viewpoints

1. Bupivacaine
2. Ropivacaine
3. Lidocaine
4. Chloroprocaine
5. Prilocaine
6. Benzocaine
7. Other local anesthetics

Reimbursement Policy - United States Anesthesia Drugs Market breakup by 2 viewpoints

1. Private Health Insurance Providers

a) Aetna International
b) Coventry Health Care
c) Anthem Blue Cross and Blue Shield
d) Blue Cross and Blue Shield of Texas
e) United Healthcare
f) State Exceptions

2. Public Health Insurance Providers

a) Medicare
b) MDWise

All key players have been covered from 3 viewpoints

• Overview
• Recent Developments
• Revenue

Company Analysis:

1. Baxter International Inc.
2. Abbvie
3. Endo International plc
4. Draegerwerk AG
5. Koninklijke Philips NV

Table of Contents

155 Pages
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. United States Anesthesia Drugs Market
6. Market Share – United States Anesthesia Drugs Analysis
6.1 Anesthesia Drugs
6.2 General Intravenous Anesthesia Drugs
6.3 Local Anesthesia Drugs
7. Types – United States Anesthesia Drugs Market
7.1 General Intravenous Anesthesia Drugs Market
7.2 General Inhalation Anesthesia Drugs Market
7.3 Local Anesthesia Drugs Market
8. General Intravenous Anesthesia Drugs Market
8.1 Propofol
8.2 Benzodiazepines Class (Diazepam and Midazolam)
8.3 Fospropofol Disodium
8.4 Ketamine
8.5 Methohexital Sodium
8.6 Pentobarbital
8.7 Etomidate
8.8 Fentanyl
9. General Inhalation Anesthesia Drugs Market
9.1 Sevoflurane
9.2 Desflurane
9.3 Isoflurane
9.4 Others
10. Local Anesthesia Drugs Market
10.1 Bupivacaine
10.2 Ropivacaine
10.3 Lidocaine
10.4 Chloroprocaine
10.5 Prilocaine
10.6 Benzocaine
10.7 Other local anesthetics
11. Merger & Acquisition (M&A) – United States Anesthesia
12. Reimbursement Policy - United States Anesthesia Drugs Market
12.1 Private Health Insurance Providers
12.1.1 Aetna International
12.1.2 Coventry Health Care
12.1.3 Anthem Blue Cross and Blue Shield
12.1.4 Blue Cross and Blue Shield of Texas
12.1.5 United Healthcare
12.2 Public Health Insurance Providers
12.2.1 Medicare
12.2.2 MDWise
13. Porters Five Forces
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14. Company Analysis
14.1 Baxter International Inc.
14.1.1 Overview
14.1.2 Recent Developments
14.1.3 Sales Analysis
14.2 Abbvie
14.2.1 Overview
14.2.2 Recent Developments
14.2.3 Sales Analysis
14.3 Medtronic Plc
14.3.1 Overview
14.3.2 Recent Developments
14.3.3 Sales Analysis
14.4 Draegerwerk AG
14.4.1 Overview
14.4.2 Recent Developments
14.4.3 Sales Analysis
14.5 Koninklijke Philips NV
14.5.1 Overview
14.5.2 Recent Developments
14.5.3 Sales Analysis
List Of Figures:
Figure-01: United States Anesthesia Drugs Market Market (Million US$), 2016 – 2021
Figure-02: Forecast for – United States Anesthesia Drugs Market Market (Million US$), 2022 – 2027
Figure-03: Types – General Intravenous Anesthesia Drugs Market Market (Million US$), 2016 – 2021
Figure-04: Types – Forecast for General Intravenous Anesthesia Drugs Market Market (Million US$), 2022 – 2027
Figure-05: Types – General Inhalation Anesthesia Drugs Market Market (Million US$), 2016 – 2021
Figure-06: Types – Forecast for General Inhalation Anesthesia Drugs Market Market (Million US$), 2022 – 2027
Figure-07: Types – Local Anesthesia Drugs Market Market (Million US$), 2016 – 2021
Figure-08: Types – Forecast for Local Anesthesia Drugs Market Market (Million US$), 2022 – 2027
Figure-09: General Intravenous Anesthesia – Propofol Market (Million US$), 2016 – 2021
Figure-10: General Intravenous Anesthesia – Forecast for Propofol Market (Million US$), 2022 – 2027
Figure-11: General Intravenous Anesthesia – Benzodiazepines Class (Diazepam and Midazolam) Market (Million US$), 2016 – 2021
Figure-12: General Intravenous Anesthesia – Forecast for Benzodiazepines Class (Diazepam and Midazolam) Market (Million US$), 2022 – 2027
Figure-13: General Intravenous Anesthesia – Fospropofol Disodium Market (Million US$), 2016 – 2021
Figure-14: General Intravenous Anesthesia – Forecast for Fospropofol Disodium Market (Million US$), 2022 – 2027
Figure-15: General Intravenous Anesthesia – Ketamine Market (Million US$), 2016 – 2021
Figure-16: General Intravenous Anesthesia – Forecast for Ketamine Market (Million US$), 2022 – 2027
Figure-17: General Intravenous Anesthesia – Methohexital Sodium Market (Million US$), 2016 – 2021
Figure-18: General Intravenous Anesthesia – Forecast for Methohexital Sodium Market (Million US$), 2022 – 2027
Figure-19: General Intravenous Anesthesia – Pentobarbital Market (Million US$), 2016 – 2021
Figure-20: General Intravenous Anesthesia – Forecast for Pentobarbital Market (Million US$), 2022 – 2027
Figure-21: General Intravenous Anesthesia – Etomidate Market (Million US$), 2016 – 2021
Figure-22: General Intravenous Anesthesia – Forecast for Etomidate Market (Million US$), 2022 – 2027
Figure-23: General Intravenous Anesthesia – Fentanyl Market (Million US$), 2016 – 2021
Figure-24: General Intravenous Anesthesia – Forecast for Fentanyl Market (Million US$), 2022 – 2027
Figure-25: General Inhalation Anesthesia – Sevoflurane Market (Million US$), 2016 – 2021
Figure-26: General Inhalation Anesthesia – Forecast for Sevoflurane Market (Million US$), 2022 – 2027
Figure-27: General Inhalation Anesthesia – Desflurane Market (Million US$), 2016 – 2021
Figure-28: General Inhalation Anesthesia – Forecast for Desflurane Market (Million US$), 2022 – 2027
Figure-29: General Inhalation Anesthesia – Isoflurane Market (Million US$), 2016 – 2021
Figure-30: General Inhalation Anesthesia – Forecast for Isoflurane Market (Million US$), 2022 – 2027
Figure-31: General Inhalation Anesthesia – Others Market (Million US$), 2016 – 2021
Figure-32: General Inhalation Anesthesia – Forecast for Others Market (Million US$), 2022 – 2027
Figure-33: Local Anesthesia – Bupivacaine Market (Million US$), 2016 – 2021
Figure-34: Local Anesthesia – Forecast for Bupivacaine Market (Million US$), 2022 – 2027
Figure-35: Local Anesthesia – Ropivacaine Market (Million US$), 2016 – 2021
Figure-36: Local Anesthesia – Forecast for Ropivacaine Market (Million US$), 2022 – 2027
Figure-37: Local Anesthesia – Lidocaine Market (Million US$), 2016 – 2021
Figure-38: Local Anesthesia – Forecast for Lidocaine Market (Million US$), 2022 – 2027
Figure-39: Local Anesthesia – Chloroprocaine Market (Million US$), 2016 – 2021
Figure-40: Local Anesthesia – Forecast for Chloroprocaine Market (Million US$), 2022 – 2027
Figure-41: Local Anesthesia – Prilocaine Market (Million US$), 2016 – 2021
Figure-42: Local Anesthesia – Forecast for Prilocaine Market (Million US$), 2022 – 2027
Figure-43: Local Anesthesia – Benzocaine Market (Million US$), 2016 – 2021
Figure-44: Local Anesthesia – Forecast for Benzocaine Market (Million US$), 2022 – 2027
Figure-45: Local Anesthesia – Other local anesthetics Market (Million US$), 2016 – 2021
Figure-46: Local Anesthesia – Forecast for Other local anesthetics Market (Million US$), 2022 – 2027
Figure-47: Baxter International Inc. – Global Revenue (Million US$), 2016 – 2021
Figure-48: Baxter International Inc. – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-49: Abbvie – Global Revenue (Million US$), 2016 – 2021
Figure-50: Abbvie – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-51: Medtronic Plc – Global Revenue (Million US$), 2016 – 2021
Figure-52: Medtronic Plc – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-53: Draegerwerk AG – Global Revenue (Million US$), 2016 – 2021
Figure-54: Draegerwerk AG – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-55: Koninklijke Philips NV – Global Revenue (Million US$), 2016 – 2021
Figure-56: Koninklijke Philips NV – Forecast for Global Revenue (Million US$), 2022 – 2027
List Of Tables:
Table-01: Anesthesia Drugs Market Share (Million US$), 2016 – 2021
Table-02: Forecast for – Anesthesia Drugs Market Share (Million US$), 2022 – 2027
Table-03: General Intravenous Anesthesia Drugs Market Share (Million US$), 2016 – 2021
Table-04: Forecast for – General Intravenous Anesthesia Drugs Market Share (Million US$), 2022 – 2027
Table-05: General Inhalation Anesthesia Drugs Market Market Share (Million US$), 2016 – 2021
Table-06: Forecast for – General Inhalation Anesthesia Drugs Market Market Share (Million US$), 2022 – 2027
Table-07: Local Anesthesia Drugs Market Share (Million US$), 2016 – 2021
Table-08: Forecast for – Local Anesthesia Drugs Market Share (Million US$), 2022 – 2027

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us